Related Experiment Video
Updated: Aug 5, 2026
09:52
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Management of malignant melanoma
1Department of Dermatology, Waikato Hospital, Hamilton.
The New Zealand Medical Journal
|May 11, 1994
Summary
This study provides a framework for general practitioners to manage malignant melanoma patients. It acknowledges ongoing debates in melanoma treatment, with evolving recommendations based on new research into atypical moles.
Area of Science:
- Dermatology
- Oncology
Background:
- Current consensus on melanoma management has limitations.
- Areas of contention exist within melanoma treatment protocols.
- Evolving knowledge of atypical naevi (moles) influences management strategies.
Purpose of the Study:
- To provide general practitioners with a management framework for malignant melanoma.
- To guide the planning and treatment of patients with melanoma.
- To address existing gaps and controversies in melanoma care.
Main Methods:
- Review of current literature and consensus guidelines.
- Synthesis of evidence regarding melanoma aetiology and natural history.
- Development of a practical framework for primary care physicians.
Main Results:
- Identified key areas of contention in current melanoma management.
- Highlighted the impact of new research on atypical naevi.
- Established a structured approach for general practitioner decision-making.
Conclusions:
- The provided framework aims to improve melanoma patient management by general practitioners.
- Further research into atypical naevi will likely refine future recommendations.
- Addressing areas of contention is crucial for advancing melanoma care.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.